TY - JOUR
KW - Humans
KW - Methadone/therapeutic use
KW - Nova Scotia
KW - Nurse Practitioners
KW - Opiate Substitution Treatment/methods
KW - Opioid-Related Disorders/drug therapy
KW - Addiction
KW - Methadone
KW - opioid use disorder
KW - prescription
KW - primary care
AU - A. E. Bates
AU - R. Martin-Misener
A1 - 
AB - BACKGROUND: Opioid use has escalated dramatically resulting in an increase in deaths. Access to treatment for opioid use disorder (OUD) is poor. The addition of nurse practitioners (NPs) as prescribers of methadone for OUD offers potential for improving access. Little is known about what support NPs will require as they prescribe methadone. PURPOSE: This paper identifies facilitators and barriers to NPs prescribing methadone. METHODS: In this qualitative study, in-person and phone semi-structured interviews were conducted with 18 participants. Participants included NPs (n=5), physicians (n=5), and stakeholders including members of professional regulatory bodies and government, academics and other clinicians (n=8). Interviews were recorded, transcribed, and analyzed using thematic analysis and software (NVivo 12.4.0) for data management. RESULTS: Four themes emerged: 1) Pervasive Barrier of Stigma; 2) Perceived Complexity of Patients Living with OUD; 3) NP Education and Practice Supports and; 4) Health Care Context and NP Role Implementation. CONCLUSIONS: Barriers and facilitators to NP prescribing are similar to those encountered by physicians. Factors unique to NPs include the identification of role clarity as a facilitator and navigation of physician networks as a barrier. Research conducted with current NP methadone prescribers is required to evaluate implementation of this service.
AD - Faculty of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada.; School of Nursing, Dalhousie University, Halifax, Nova Scotia, Canada.
BT - The Canadian journal of nursing research = Revue canadienne de recherche en sciences infirmieres
C5 - Education & Workforce; Opioids & Substance Use
CP - 1
DO - 10.1177/0844562121996222
IS - 1
JF - The Canadian journal of nursing research = Revue canadienne de recherche en sciences infirmieres
LA - eng
M1 - Journal Article
N2 - BACKGROUND: Opioid use has escalated dramatically resulting in an increase in deaths. Access to treatment for opioid use disorder (OUD) is poor. The addition of nurse practitioners (NPs) as prescribers of methadone for OUD offers potential for improving access. Little is known about what support NPs will require as they prescribe methadone. PURPOSE: This paper identifies facilitators and barriers to NPs prescribing methadone. METHODS: In this qualitative study, in-person and phone semi-structured interviews were conducted with 18 participants. Participants included NPs (n=5), physicians (n=5), and stakeholders including members of professional regulatory bodies and government, academics and other clinicians (n=8). Interviews were recorded, transcribed, and analyzed using thematic analysis and software (NVivo 12.4.0) for data management. RESULTS: Four themes emerged: 1) Pervasive Barrier of Stigma; 2) Perceived Complexity of Patients Living with OUD; 3) NP Education and Practice Supports and; 4) Health Care Context and NP Role Implementation. CONCLUSIONS: Barriers and facilitators to NP prescribing are similar to those encountered by physicians. Factors unique to NPs include the identification of role clarity as a facilitator and navigation of physician networks as a barrier. Research conducted with current NP methadone prescribers is required to evaluate implementation of this service.
PY - 2022
SN - 1705-7051; 0844-5621; 0844-5621
SP - 15
EP - 26
EP - 
T1 - Facilitators and Barriers to Nurse Practitioners Prescribing Methadone for Opioid Use Disorder in Nova Scotia: A Qualitative Study
T2 - The Canadian journal of nursing research = Revue canadienne de recherche en sciences infirmieres
TI - Facilitators and Barriers to Nurse Practitioners Prescribing Methadone for Opioid Use Disorder in Nova Scotia: A Qualitative Study
U1 - Education & Workforce; Opioids & Substance Use
U2 - 33615847
U3 - 10.1177/0844562121996222
VL - 54
VO - 1705-7051; 0844-5621; 0844-5621
Y1 - 2022
Y2 - Mar
ER -